Core Laboratories EBITDA Margin 2010-2023 | CLB
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Core Laboratories (CLB) over the last 10 years. The current EBITDA margin for Core Laboratories as of December 31, 2023 is .
| Core Laboratories EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$0.51B |
$0.07B |
13.95% |
| 2023-09-30 |
$0.51B |
$0.07B |
14.34% |
| 2023-06-30 |
$0.51B |
$0.07B |
14.31% |
| 2023-03-31 |
$0.50B |
$0.07B |
13.12% |
| 2022-12-31 |
$0.49B |
$0.06B |
12.04% |
| 2022-09-30 |
$0.49B |
$0.06B |
11.91% |
| 2022-06-30 |
$0.48B |
$0.05B |
10.44% |
| 2022-03-31 |
$0.48B |
$0.05B |
10.90% |
| 2021-12-31 |
$0.47B |
$0.06B |
13.62% |
| 2021-09-30 |
$0.46B |
$0.07B |
15.90% |
| 2021-06-30 |
$0.45B |
$0.08B |
17.49% |
| 2021-03-31 |
$0.44B |
$0.06B |
14.22% |
| 2020-12-31 |
$0.49B |
$-0.06B |
-11.70% |
| 2020-09-30 |
$0.53B |
$-0.06B |
-10.94% |
| 2020-06-30 |
$0.60B |
$-0.04B |
-6.19% |
| 2020-03-31 |
$0.65B |
$-0.01B |
-0.92% |
| 2019-12-31 |
$0.67B |
$0.12B |
17.96% |
| 2019-09-30 |
$0.68B |
$0.12B |
17.11% |
| 2019-06-30 |
$0.69B |
$0.12B |
17.46% |
| 2019-03-31 |
$0.70B |
$0.13B |
18.03% |
| 2018-12-31 |
$0.70B |
$0.14B |
20.29% |
| 2018-09-30 |
$0.70B |
$0.16B |
22.38% |
| 2018-06-30 |
$0.68B |
$0.15B |
21.83% |
| 2018-03-31 |
$0.66B |
$0.14B |
21.63% |
| 2017-12-31 |
$0.65B |
$0.14B |
20.83% |
| 2017-09-30 |
$0.62B |
$0.13B |
20.22% |
| 2017-06-30 |
$0.60B |
$0.12B |
20.07% |
| 2017-03-31 |
$0.59B |
$0.11B |
19.22% |
| 2016-12-31 |
$0.59B |
$0.11B |
19.32% |
| 2016-09-30 |
$0.63B |
$0.12B |
18.47% |
| 2016-06-30 |
$0.68B |
$0.14B |
20.82% |
| 2016-03-31 |
$0.74B |
$0.17B |
23.04% |
| 2015-12-31 |
$0.80B |
$0.19B |
23.68% |
| 2015-09-30 |
$0.89B |
$0.26B |
28.52% |
| 2015-06-30 |
$0.97B |
$0.30B |
30.52% |
| 2015-03-31 |
$1.04B |
$0.33B |
32.02% |
| 2014-12-31 |
$1.09B |
$0.37B |
34.25% |
| 2014-09-30 |
$1.08B |
$0.37B |
34.07% |
| 2014-06-30 |
$1.08B |
$0.37B |
33.80% |
| 2014-03-31 |
$1.08B |
$0.36B |
33.77% |
| 2013-12-31 |
$1.07B |
$0.36B |
33.46% |
| 2013-09-30 |
$1.05B |
$0.35B |
32.92% |
| 2013-06-30 |
$1.02B |
$0.34B |
32.84% |
| 2013-03-31 |
$1.01B |
$0.33B |
32.27% |
| 2012-12-31 |
$0.98B |
$0.32B |
32.65% |
| 2012-09-30 |
$0.97B |
$0.32B |
32.78% |
| 2012-06-30 |
$0.96B |
$0.31B |
31.90% |
| 2012-03-31 |
$0.94B |
$0.29B |
31.23% |
| 2011-12-31 |
$0.91B |
$0.27B |
30.18% |
| 2011-09-30 |
$0.87B |
$0.26B |
30.05% |
| 2011-06-30 |
$0.84B |
$0.26B |
30.83% |
| 2011-03-31 |
$0.81B |
$0.25B |
31.24% |
| 2010-12-31 |
$0.79B |
$0.25B |
31.36% |
| 2010-09-30 |
$0.77B |
$0.23B |
30.21% |
| 2010-06-30 |
$0.74B |
$0.22B |
29.31% |
| 2010-03-31 |
$0.71B |
$0.22B |
30.50% |
| 2009-12-31 |
$0.70B |
$0.21B |
30.17% |
| Sector |
Industry |
Market Cap |
Revenue |
| Oils/Energy |
Oil & Gas - Field Services |
$0.796B |
$0.510B |
|
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry principally in the United States, Canada and internationally. Core Laboratories Inc., formerly known as CORE LABS NV, is based in Houston, Texas.
|
